With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

This webinar is the third of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover:
• Current health economics stance on precision medicine applications
• What we know and what we don’t know about precision medicine cost-utility
• How costs may evolve with emerging technologies or trends
• Priorities for future HTA research in this area

At the end of this session, participants will be aware of:
• The impact of precision medicine advancements on health technology assessment
• The economic arguments for and against precision medicine
• International coordination in health technology assessment policies for precision medicine

Moderator:
- Donnacha Fitzgerald, Predoctoral Fellow, The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital - Germany

Panellists:
- Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA
- IÑAKI GUTIERREZ-IBARLUZEA, Board Director and Former President Health Technology Assessment International (HTAi), Spain

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

FIPWiSE (Women in Science and Education) is a programme that was launched by the International Pharmaceutical Federation (FIP) on 11 February 2020 on the United Nations’ International Day of Women and Girls in Science. Three years since its launch, several initiatives and transformation tools were introduced including FIPWiSE Toolkit for Positive Practice Environments for Women in Science and Education, FIPWiSE Rising Stars List, Women Leadership Lab, Fearless Podcast Series and Mentorship Programme

This special event is hosted so that, together, we can celebrate the 3^rd year anniversary of FIPWiSE. We will be revisiting the key outcomes delivered, reflecting on their successes, impacts and lessons, and discussing a future for FIPWiSE with the widest reach and social value. We want to reflect how FIPWiSE supports women to in pharmacy achieve their fullest potential, and to attract female students and young professionals into these fields. 

Learning objectives:

1. Celebrate the United Nations’ International Day of Women and Girls in Science.
2. Understand the aim and scope of the FIPWiSE programme and its key initiatives.
3. Discuss how the initiative can further support women in pharmaceutical science and education into the future.

Participants: 
- Catherine Duggan, FIP CEO, The Netherland
- Claire Thompson, FIPWiSE Chair, CEO Agility Life Sciences, UK
- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, FIP, The Netherlands
- Zuzana Kusynova, FIP Lead for Policy, Practice and Compliance, FIP, The Netherlands
- Aysu Selcuk, FIP Educational and Primary Health Care Policies Specialist, FIP - The Netherlands
- Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, FIP, The Netherlands
- Alison Etukakpan, FIP Educational Partnership Specialist, FIPt, The Netherlands
- Lilian Azzopardi, Head, Department of Pharmacy University of Malta, Malta
- Charlotte Rossing, Director of Research and Development, The Danish College of Pharmacy Practice, Denmark
- Marilyn Morris, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences University at Buffalo, US
- Dalal Hammoudi Halat, Common Year Coordinator - QU Health, Qatar University, Qatar

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.

Attendees will learn about:

1. The role of pharmacy professionals in point-of-care testing;
2. The importance of providing point-of-care testing services in the screening and management of chronic non-communicable diseases and acute situations;
3. Challenges and opportunities for pharmacists in addressing point-of-care testing services.

Moderator:
- Daragh Connolly, Chair of the FIP Board of Pharmaceutical Practice, Ireland

Panellists:
- Sherif Guorgui, President, FIP Community Pharmacy Section, Canada
- Julien Fonsart, Head of the Clinical Biology laboratory, Saint-Louis Lariboisiere University Hospitals, Greater Paris University Hospitals (APHP), France
- Teresa Torres. General Director of GO FAR ANF, Portugal
- Efi Mantzourani, Reader in Pharmacy Practice / Research and Evaluation Lead in Choose Pharmacy, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University / Primary Care, Digital Health and Care Wales, NHS Wales, UK

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).